Autopsy report · NCT04272268
Feasibility and Safety of Using Nasal High Flow Oxygen Postoperatively to Reduce Respiratory Complications
Cause of deathStaffing, sites or logistics
“Covid-19”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- University Hospitals of North Midlands NHS Trust
- Sponsor type
- University, hospital or other
- Conditions
- Cancer of the Esophagus
- Interventions
- Nasal High flow Oxygen
- Participants
- 0
- Sites
- 1
- Countries
- United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.